Study supports PSA screening for male BRCA2 carriers
(HealthDay)—Systematic prostate-specific antigen (PSA) screening is advised for men who are carriers of the BRCA2 mutation, which is associated with a higher incidence of prostate cancer, younger age at diagnosis, and clinically ...
Nov 27, 2019
0
2